Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

DELTA VARIANT BLAMED FOR SPIKE IN CASES IN INDONESIA

The COVID-19 Delta variant—known as B.1.617.2—has been blamed for the increase in virus cases in Indonesia, forcing the government in Jakarta to hold off on easing restrictions.
The Wall Street Journal reported that there is no specific number on how many cases are tied to the variant, but one epidemiologist told the paper that the country could be the next to get hit with a “tsunami” of cases.
The country has been absorbing about 10,000 new cases each day, but a third of those given a PCR test have tested positive, which health officials say is evidence that the virus is far more widespread than thought.
The paper said less than 5 percent of the country’s 270 million have been fully vaccinated, and China’s Sinovac has been its largest supplier. The Pfizer and AstraZeneca vaccines have proven effective in preventing disease, but the paper pointed out that the studies did not include the Chinese offering. 
Reuters reported that more than 350 doctors and medical staff came down with the virus in the country after having already received the Chinese jab. Some of the medical workers have been hospitalized.
“The data shows they have the Delta variant so it is no surprise that the breakthrough infection is higher than before,” Dicky Budman, an epidemiologist at Australia’s Griffith Univerisity said. “Because, as we know, the majority of health care workers in Indonesia got Sinovac, and we still don’t know yet how effective it is in the real world against the Delta variant.”
The current wave is being blamed, in part, on the celebrations during the Muslim holiday Eid last month.

Comments are closed.